Exagen Inc
NASDAQ:XGN
Exagen Inc
NASDAQ:XGN
Price:
3.225
USD
0.16%
Market Cap:
$73.1m
Balance Sheet
Balance Sheet Decomposition
Exagen Inc
Exagen Inc
Balance Sheet Decomposition is not available for
Exagen Inc
Exagen Inc
Balance Sheet
Exagen Inc
Exagen Inc
Currency: USD
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
3
|
8
|
5
|
11
|
13
|
72
|
57
|
99
|
62
|
36
|
22
|
|
| Cash Equivalents |
3
|
8
|
5
|
11
|
13
|
72
|
57
|
99
|
62
|
36
|
22
|
|
| Total Receivables |
0
|
0
|
0
|
1
|
6
|
6
|
9
|
10
|
6
|
7
|
8
|
|
| Accounts Receivables |
0
|
0
|
0
|
1
|
6
|
6
|
9
|
10
|
6
|
7
|
8
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
1
|
0
|
1
|
1
|
2
|
4
|
4
|
4
|
4
|
5
|
7
|
|
| Total Current Assets |
4
|
8
|
5
|
13
|
21
|
81
|
71
|
113
|
73
|
48
|
36
|
|
| PP&E Net |
1
|
1
|
2
|
1
|
2
|
1
|
2
|
5
|
13
|
8
|
8
|
|
| PP&E Gross |
1
|
1
|
2
|
0
|
0
|
0
|
0
|
5
|
13
|
8
|
8
|
|
| Accumulated Depreciation |
1
|
1
|
2
|
0
|
0
|
0
|
0
|
4
|
5
|
6
|
6
|
|
| Intangible Assets |
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Goodwill |
6
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
1
|
4
|
0
|
1
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Other Assets |
6
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
0
|
0
|
0
|
|
| Total Assets |
11
N/A
|
17
+46%
|
17
+4%
|
20
+19%
|
29
+42%
|
88
+206%
|
78
-11%
|
123
+57%
|
86
-30%
|
57
-34%
|
45
-22%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
0
|
0
|
2
|
2
|
1
|
2
|
3
|
3
|
3
|
3
|
4
|
|
| Accrued Liabilities |
0
|
1
|
3
|
3
|
4
|
4
|
5
|
6
|
5
|
8
|
9
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
9
|
19
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Other Current Liabilities |
0
|
0
|
3
|
0
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
2
|
11
|
26
|
5
|
9
|
6
|
9
|
9
|
10
|
12
|
14
|
|
| Long-Term Debt |
1
|
0
|
0
|
19
|
25
|
26
|
27
|
28
|
30
|
20
|
20
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
3
|
5
|
5
|
1
|
2
|
1
|
1
|
1
|
5
|
3
|
2
|
|
| Total Liabilities |
6
N/A
|
16
+150%
|
31
+95%
|
25
-20%
|
36
+42%
|
33
-8%
|
37
+12%
|
39
+5%
|
44
+14%
|
34
-22%
|
35
+3%
|
|
| Equity | ||||||||||||
| Common Stock |
10
|
23
|
25
|
92
|
105
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
61
|
74
|
89
|
148
|
153
|
165
|
181
|
208
|
256
|
279
|
294
|
|
| Additional Paid In Capital |
56
|
52
|
51
|
51
|
41
|
220
|
223
|
293
|
298
|
302
|
304
|
|
| Total Equity |
5
N/A
|
1
-90%
|
14
N/A
|
5
+67%
|
7
-46%
|
56
N/A
|
42
-25%
|
85
+103%
|
43
-50%
|
23
-47%
|
10
-58%
|
|
| Total Liabilities & Equity |
11
N/A
|
17
+46%
|
17
+4%
|
20
+19%
|
29
+42%
|
88
+206%
|
78
-11%
|
123
+57%
|
86
-30%
|
57
-34%
|
45
-22%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
12
|
12
|
12
|
12
|
12
|
13
|
13
|
16
|
17
|
17
|
18
|
|
Switch to:
Switch to:
See Also
Discover More
